Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Intellectual Disability × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 53 Carcinoma, Renal Cell 30 Neoplasm Metastasis 28 Neoplasms 19 Neuroendocrine Tumors 17 Kidney Neoplasms 17 Recurrence 14 Prostatic Neoplasms 13 Head and Neck Neoplasms 11 Triple Negative Breast Neoplasms 10 Tuberous Sclerosis 9 Hodgkin Disease 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Pancreatic Neoplasms 8 Lymphoma, Mantle-Cell 8 Lymphoma, Large B-Cell, Diffuse 8 Glioblastoma 8 Brain Neoplasms 8 Waldenstrom Macroglobulinemia 7 Lymphoma 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Glioma 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Neuroendocrine 7 Sarcoma 6 Multiple Myeloma 6 Meningioma 6 Melanoma 6 Lymphoma, Follicular 6

Interventions

Restraint, Physical 1 Population Groups 1 Play Therapy 1 Magnetoencephalography 1 Everolimus 1 Educational Status 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01730209 2015-05-05

RAPIT

Erasmus Medical Center

Phase 2/3 Unknown

Autistic Disorder, Intellectual Disability, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡